Overview
Benign neoplasms of the heart are relatively rare but can present significant clinical challenges due to their potential impact on cardiac function and hemodynamics. These tumors encompass a variety of histological types, with myxomas being the most common, followed by lipomas and fibromas. The clinical presentation can range from asymptomatic to severe symptoms depending on the tumor's location, size, and effects on cardiac structures. Early diagnosis and appropriate management are crucial for optimal outcomes, often involving surgical intervention for larger or symptomatic tumors. This guideline synthesizes evidence from multiple studies to provide a comprehensive overview of the epidemiology, clinical presentation, diagnosis, management, complications, and prognosis associated with benign heart neoplasms.
Epidemiology
Between 2009 and 2021, a significant cohort study involving 183 consecutive patients who underwent surgical intervention for cardiac tumors revealed that 169 (92.3%) were benign in nature, with myxomas constituting the predominant subtype at 54% [PMID:35997214]. This high prevalence of myxomas underscores their importance in clinical practice. The study also highlighted a broad age spectrum, with patients ranging from young children to elderly individuals, indicating that benign heart neoplasms can affect a wide demographic. Specifically, a separate cohort analysis included 67 patients aged between 2.2 to 74 years (mean age 34.1 ± 2.1 years), further emphasizing the diverse age distribution [PMID:26762073]. Gender distribution in the larger cohort showed a slight female predominance, with 48% of the patients being female, suggesting no significant gender bias in susceptibility [PMID:35997214]. These findings collectively highlight the need for vigilance across all age groups and genders when evaluating cardiac masses.
Clinical Presentation
The clinical presentation of benign heart neoplasms varies widely based on the tumor's characteristics and location within the heart. A notable case involved a 71-year-old woman who presented with recurrent episodes of shortness of breath, which acutely exacerbated with dyspnoea and a hypertensive crisis, ultimately leading to the diagnosis of a right atrial lipoma [PMID:25245725]. This case exemplifies how benign tumors can cause acute hemodynamic instability. In broader clinical contexts, symptoms often include dyspnea, palpitations, syncope, and signs of systemic embolization, depending on the tumor's impact on cardiac function and potential for embolization. The study cohort analyzed by [PMID:35997214] comprised 183 patients with a mean age of 60 ± 16 years, reflecting a median age of presentation that aligns with the typical age range for cardiovascular diseases, suggesting that clinicians should maintain a high index of suspicion in older adults. Additionally, the inclusion of pediatric cases in another study [PMID:26762073] indicates that benign heart tumors can also manifest in younger patients, often presenting with nonspecific symptoms such as fatigue and exercise intolerance.
Diagnosis
Diagnosing benign heart neoplasms requires a multifaceted approach, integrating clinical suspicion with advanced imaging modalities. Echocardiography remains the initial diagnostic tool due to its non-invasive nature and ability to visualize cardiac structures. In the case of the 71-year-old woman with a right atrial lipoma, echocardiography was pivotal in identifying the mass, complemented by computed tomography (CT) for further characterization [PMID:25245725]. CT and magnetic resonance imaging (MRI) provide detailed anatomical information and help differentiate between various tumor types based on their echogenicity and tissue characteristics. However, early diagnosis can be challenging, as highlighted by a comprehensive study spanning from December 1962 to December 2014 involving 336 patients with cardiac pseudotumors [PMID:26762073]. This study underscored the diagnostic difficulties, often attributed to subtle clinical presentations and the need for high-resolution imaging techniques to confirm the benign nature of the mass. In clinical practice, a combination of echocardiography, CT, and MRI, along with histopathological examination post-surgical resection, ensures accurate diagnosis and classification of benign heart neoplasms.
Management
The management of benign heart neoplasms hinges on the tumor's size, location, and impact on cardiac function and hemodynamics. Surgical intervention remains the gold standard for symptomatic tumors or those posing a risk of embolization or hemodynamic compromise. The successful surgical removal of the right atrial lipoma in the aforementioned case involved open heart surgery with cardiopulmonary bypass, including meticulous reconstruction of the right atrium and vena cava orifices [PMID:25245725]. This approach underscores the necessity of specialized surgical techniques to ensure complete resection and minimize complications. For benign tumors, surgery is highly effective and curative, with studies reporting excellent long-term outcomes [PMID:35997214]. However, specific surgical techniques such as normothermic or hypothermic perfusion and the use of pharmaco-cold cardioplegia are crucial to protect the myocardium and prevent tumor fragmentation that could lead to embolic events [PMID:26762073].
For smaller, asymptomatic tumors, medical management may be considered. These neoplasms are typically characterized by non-displaceability, homogeneous echogenicity, clear outlines, and the absence of hemodynamic disturbances or clinical symptoms [PMID:26762073]. Regular monitoring through imaging studies is essential to detect any changes that might necessitate surgical intervention. The decision to pursue surgical versus conservative management should be individualized based on patient-specific factors and tumor characteristics.
Complications
Complications associated with benign heart neoplasms can be significant and multifaceted, often necessitating comprehensive surgical management. In the case of the 71-year-old woman, the presence of a coexisting patent foramen ovale (PFO) required careful surgical consideration to prevent potential paradoxical embolism post-operatively [PMID:25245725]. This highlights the importance of thorough preoperative evaluation to identify and address concurrent cardiac anomalies. Postoperative complications can include arrhythmias, infection, and mechanical dysfunction related to surgical interventions. The study by [PMID:35997214] reported a mean hospital stay of 11 ± 6.5 days following surgical resection, indicating the need for extended recovery periods and close monitoring for complications such as wound infections and cardiac rhythm disturbances. Additionally, the risk of tumor embolization during surgery necessitates meticulous surgical techniques to minimize these risks.
Prognosis & Follow-up
The prognosis for patients undergoing surgical resection of benign heart neoplasms is generally favorable, with no recurrence observed in many cases post-surgery. The aforementioned patient with a right atrial lipoma showed no tumor recurrence during follow-up visits [PMID:25245725]. However, long-term follow-up remains crucial due to the potential for late recurrence or complications. Studies have reported encouraging survival rates, with a 1-year survival rate of 100% and a 24-year survival rate of 94.3% without hospital mortality [PMID:26762073]. Despite these positive outcomes, the all-cause mortality rate at ten years post-surgery was noted to be 14% in another cohort [PMID:35997214], emphasizing the importance of continued surveillance even in patients with successful surgical outcomes. Regular echocardiograms and clinical assessments are recommended to monitor for any signs of recurrence or new cardiac issues, ensuring optimal long-term management and quality of life for these patients.
References
1 Habertheuer A, Andreas M, Wiedemann D, Rath C, Kocher A. A rare case of obstructive right atrial lipoma. Annals of the Royal College of Surgeons of England 2014. link 2 Gaisendrees C, Gerfer S, Schröder C, Schlachtenberger G, Walter S, Ivanov B et al.. Benign and malignant cardiac masses: long-term outcomes after surgical resection. Expert review of anticancer therapy 2022. link 3 Kuznetsova LM, Nechayenko MA, Podolyak DG, Kiprenskiy AY, Aksyuk MA. The diagnosis and surgical treatment of cardiac pseudotumors. Khirurgiia 2015. link